CD4 and neoplasm: The immunosuppressive effect of these M-MDSCs on CD4+ T cells was found primarily to be due to the increased IL-10 production, which in turn, inhibited anti-tumour immune responses, through inhibiting the production of IFN-γ and IL-12, and therefore enhancing tumour growth.